Bioregenx (BRGX) Cash from Operations (2022 - 2026)
Bioregenx's (BRGX) quarterly Cash from Operations came in at 26629.0 in Q1 2026, down 29.36% year-on-year from 37695.0 in Q1 2025, and down 61.76% quarter-over-quarter from 69636.0 in Q4 2025.
Bioregenx (BRGX) Cash from Operations (2022 - 2026) Analysis & Trends
Bioregenx's Cash from Operations history runs 5 years deep, the most recent figure standing at 26629.0 for Q1 2026.
- On a quarterly basis, Cash from Operations fell 29.36% year-over-year to 26629.0 in Q1 2026; TTM through Mar 2026 was 27906.0, a 115.32% increase from a year earlier, with the FY2025 full-year figure at 38972.0, up 112.02% from the prior year.
- Cash from Operations declined to 26629.0 in Q1 2026 per BRGX's latest filing, from 69636.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 69636.0 in Q4 2025 and bottomed at 649161.0 in Q2 2023.
- The 5-year median for Cash from Operations is 31196.0 (2024), against an average of 108131.88.
- Across the five-year window, Cash from Operations sank 5528.46% in 2023 and jumped 712.94% in 2025, its largest moves.
- Year by year, Cash from Operations stood at 4364.0 in 2022, then sank by 5528.46% to 245626.0 in 2023, then jumped by 95.37% to 11361.0 in 2024, then soared by 712.94% to 69636.0 in 2025, then slumped by 61.76% to 26629.0 in 2026.
- Per Business Quant, the three latest BRGX Cash from Operations figures stand at 26629.0 (Q1 2026), 69636.0 (Q4 2025), and 71564.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 29.34 Bn | 22.03 Bn | 662.02 Mn | 1.13 Bn |
| 2 | BrightSpring Health Services | 13.49 Bn | 12.59 Bn | 482.22 Mn | 122.94 Mn |
| 3 | Healthequity | 7.96 Bn | 7.70 Bn | 256.31 Mn | 97.53 Mn |
| 4 | 10x Genomics | 6.17 Bn | 5.63 Bn | 106.18 Mn | 26.12 Mn |
| 5 | Hinge Health | 6.02 Bn | 5.70 Bn | 154.23 Mn | 43.08 Mn |
| 6 | MiniMed | 4.19 Bn | 3.89 Bn | 480.00 Mn | -170.00 Mn |
| 7 | Waystar Holding | 4.14 Bn | 4.07 Bn | 216.84 Mn | 84.91 Mn |
| 8 | Doximity | 3.82 Bn | 3.08 Bn | 125.97 Mn | 109.52 Mn |
| 9 | Privia Health | 3.10 Bn | 2.73 Bn | - | -49.47 Mn |
| 10 | Bioregenx | 9.69 Mn | 9.65 Mn | 348,288.00 | 26,629.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26,629.00 |
| Mar 31, 2026 | 26,629.00 |
| Dec 31, 2025 | 69,636.00 |
| Dec 31, 2025 | 69,636.00 |
| Sep 30, 2025 | -71,564.00 |
| Sep 30, 2025 | -71,564.00 |
| Jun 30, 2025 | 3,205.00 |
| Jun 30, 2025 | 3,205.00 |
| Mar 31, 2025 | 37,695.00 |
| Mar 31, 2025 | 37,695.00 |
| Dec 31, 2024 | -11,361.00 |
| Dec 31, 2024 | -11,361.00 |
| Sep 30, 2024 | -31,196.00 |
| Sep 30, 2024 | -31,196.00 |
| Jun 30, 2024 | -177,341.00 |
| Jun 30, 2024 | -177,341.00 |
| Mar 31, 2024 | -104,250.00 |
| Mar 31, 2024 | -104,250.00 |
| Dec 31, 2023 | -245,626.00 |
| Dec 31, 2023 | -245,626.00 |